Nasus Pharma Ltd. (NSRX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Nasus Pharma Ltd. (NSRX) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $26.8M, listed on AMEX, employing roughly 7 people, carrying a beta of 3.93 to the broader market. Nasus Pharma Ltd. Led by Dan Teleman, public since 2025-08-13.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for NSRX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →